Market News / Story
PacBio Deepens AI Drug-Discovery Push With TychoBio Deal — PACB Stock Takes A Breather After 103% Rally
Stocktwits ·
Stocktwits reports: PacBio (PACB) was on investors’ radar on Tuesday after the biotech firm announced a partnership with TychoBio, pushing it deeper into AI-based drug discovery. After an eight-session rally that more than doubled its value, PACB shares tumbled over 6% as of this writing. PacBio To Generate Data From More Than 10,000 Samples Under the agreement, PacBio will generate full-length RNA data from more than 10,000 samples, which TychoBio will use to train AI models to design…